Series C - Cerebral Therapeutics

Series C - Cerebral Therapeutics

Investment Firm

Overview

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Announced Date

Jun 28, 2022

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorPerceptive Advisors
Participant InvestorRA Capital Management
Participant InvestorGranite Point Capital
Participant InvestorVivo Capital

Round Details and Background

Cerebral Therapeutics raised $40000000 on 2022-06-28 in Series C

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 20, 2018
Series A - Cerebral Therapeutics
2-3.0M
Mar 08, 2019
Series A - Cerebral Therapeutics
2-7.8M
Jan 06, 2020
Series B - Cerebral Therapeutics
4-35.0M
Jun 28, 2022
Series C - Cerebral Therapeutics
5-40.0M

Recent Activity

There is no recent news or activity for this profile.